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Magnetic resonance imaging and histological studies on the behavior of a monomer stabilized
superparamagnetic contrast medium for Magnetic Resonance Angiography in rat model
The aim of the present study was to investigate a new, monomer-coated superparamagnetic
contrast medium for magnetic resonance angiography. This was done by magnetic resonance
imaging (MRI) and histologic examinations performed to characterize the contrast medium
VSOP-C63 in the rat model. A total of 101 rats were examined to determine the optimal dose
and the blood half-life as well as the distribution and degradation of the contrast medium in
connection with a histopathologic evaluation.
The MRI results obtained with a high-resolution 3D FLASH sequence showed a prolonged
intravascular signal increase for all dosages (15, 30, 45, 60, 75 and 90 mmol/kg body mass
(BM)) tested in 36 rats. The observed signal increase allowed for even delineating small,
second- and third-order vessels. Blood half-lives were found to be dose-dependant.
Significant differences in signal increase among the dosages tested were observed for doses
up to 75 mmol/kg BM. The dose of 90 mmol/kg BM produced an overdose effect which was
superimposed on the signal-enhancing effect at the early time points. With a time-optimized
acquisition technique, bolus injection of VSOP-C63 at a dose of 45 mmol/kg produces the
same signal-enhancing effect in the aorta as the injection of 0.2 mmol Gd/kg (Magnevistâ ).
This is due to the favorable R2-to-R1 ratio of VSOP-C63, which is 1.3 as determined at 37°C
in 0.9% NaCl using a field strength of 0.47 T.
MRI and histologic examinations in 65 rats, among them 30 control animals, revealed
differences in iron accumulation from the contrast medium between the liver and the spleen.
The signal intensities determined using a proton-density-weighted SE sequence and a
T2-weighted GRE sequence at 1.5 Tesla suggest that VSOP-C63 accumulates mainly in the
liver and to a lesser extent in the spleen. Maximal iron accumulation after administration of
the contrast medium is complete after 24 hours, when metabolization of the particles starts.
Metabolization is different in the liver and the spleen. While traces of iron from the contrast
medium can still be found in the liver after two months of continuous metabolization, the iron
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from the contrast medium completely disappears from the spleen within one week of contrast
medium injection. At one and two months after contrast medium injection, renewed signal
loss due to the beginning physiologic storage of the iron was observed. Iron determinations
revealed no age dependence in the liver tissue of rats with a body mass of up to 500 g whereas
the spleen showed a marked increase in the amount of physiologically stored iron with age.
Examination of the control animals demonstrated that the signal intensities of the spleen
changed with age. Animals with a body mass of 280 g or above, which corresponds to an age
of about 55 days, showed large amounts of iron in the spleen. Animals below this limit
displayed only slight to moderate physiologic iron storage. Since the body's intrinsic iron
stores, if they are large enough, likewise produce a signal reduction, the animals' age must be
taken into account when investigating superparamagnetic iron oxide particles. In contrast, age
plays no role for liver imaging in the age group investigated in this study (up to a  maximum
of 500 g). The two MRI sequences used in this study showed similar characteristics in the
liver and in the spleen with the more sensitive T2-weighted GRE sequence depicting a more
pronounced signal loss. The precision of the proton-density-weighted SE sequence and the
sensitivity of the T2-weighted GRE sequence together present a useful combination for
determining the signal behavior of a contrast medium dose over time.
The histologic examinations of the control animals demonstrated physiologic iron in the lungs
and kidneys but not in the liver and the heart. Following contrast medium injection, iron oxide
particles were taken up by the cells of the mononuclear phagocytosing system. This uptake
was most pronounced in the liver, where iron was predominantly taken up by
peripherolobular Kupffer's cells. Only little contrast medium iron is taken up by the spleen but
the signal loss produced is likewise pronounced due to the Spinell structure. The results
suggest that in the course of metabolization of the contrast medium iron from the liver and
spleen, there is an increase of iron storage in other organs, especially in the lungs and kidneys
but to a lesser degree also in the heart. However, one must bear in mind that these organs also
show physiologic iron storage with increasing age (Casale et al., 1981; Massie et al., 1983).
The morphometric results (number of particles, surface, and particle size) show a highly
positive correlation with the signal intensities at MRI as long as the contrast medium iron
particles preserve their Spinell structure. The surface of the iron particles in the contrast
medium animals increases one and two months after injection without any effect on the other
parameters. This observation may be attributed to a different mode of storage resulting from
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redistribution of the iron. It may be speculated that individual particles within a cell fuse to
form larger particles or a single large particle in the course of time.
The MRI data in combination with the macroscopic and histopathologic findings show that
the new contrast medium VSOP-C63 is a well-tolerated agent that is unlikely to produce any
adverse reactions at a dose of 60 m mol Fe/kg BM. With its extended equilibrium phase and
excellent imaging properties, VSOP-C63 is a promising candidate for MR angiography and
represents an alternative to the agents currently used in clinical routine.
